GlassScriptPhysician profile
David M Kaminski
NPI 1164419123
$722.75
in general payments reported to CMS, 2019-2025
8 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.26 · 2022: $160 · 2023: $147 · 2024: $109 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $27.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.01 |
| Education | $27.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $393.54 | 2022-2025 | Euflexxa |
| Regeneron Healthcare Solutions, INC. | $107.46 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $94.06 | 2024-2025 | Tremfya |
| Abbvie INC. | $50.57 | 2022 | |
| Heron Therapeutics, INC. | $29.46 | 2025 | Zynrelef |
| Pacira Therapeutics, INC. | $20.26 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.86 | 2024 | Tapestry |
| Solventum Corporation | $13.54 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaminski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.